Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.35 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17773475 | 0.88 | MAPT (0.35) | MAPTALDH1A1MEN1KMT2AHTT | |
| SCHEMBL17778353 | 0.84 | CYP17A1 (0.38) | MAPTALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL17754170 | 0.82 | MEN1 (0.44) | MAPTALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL17754027 | 0.82 | ALDH1A1 (0.38) | MAPTALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL17754171 | 0.81 | MEN1 (0.37) | MAPTALDH1A1MEN1KMT2AEPHX2 | |
| SCHEMBL17754028 | 0.81 | ALDH1A1 (0.39) | MAPTALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL17753869 | 0.80 | ALDH1A1 (0.42) | MAPTALDH1A1MEN1KMT2AATM | |
| SCHEMBL17778264 | 0.80 | THRB (0.34) | ALDH1A1THRBTSHR | |
| SCHEMBL17297646 | 0.76 | THRB (0.46) | ALDH1A1HTTTHRBTSHR | |
| SCHEMBL17778267 | 0.75 | CYP17A1 (0.33) | ALDH1A1LMNATHRBNPSR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160145186-A1 | NON-IONIC COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145186-A1 | NON-IONIC COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | AFF1, AFF2, RER1 | MAPT 4492/4885ALDH1A1 2381/4885MEN1 3688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.